Psychedelic-
assisted therapy

Psychedelic-assisted therapy combines a carefully managed psychedelic experience with psychotherapy — before, during, and after. The medicine itself is not the treatment; the therapeutic relationship and the integration work are.

Research over the past two decades has produced compelling evidence for the use of psilocybin and ketamine in the treatment of depression, PTSD, anxiety, addiction, and end-of-life distress. This is not fringe medicine — it is increasingly mainstream, and the regulatory landscape is shifting rapidly.

I work with people who are drawn to this approach for many different reasons: some have tried other treatments without success; some are simply curious about what this kind of work might open up; some are already experienced with psychedelics and want a more structured, supported context.

My approach is grounded in harm reduction, relational attunement, and respect for the intelligence of the psychedelic experience — whatever form it takes. I don't impose a single framework or promise specific outcomes.

My training includes ketamine-assisted psychotherapy, licensed psilocybin facilitation in Colorado, and the Lascaux method of psychedelic facilitation through Cardea. I bring these frameworks together rather than working from any single one.

My work is deeply informed by my broader clinical training in relational psychoanalytic theory and somatic approaches. The psychedelic container is only as good as the therapeutic relationship surrounding it.